Publications 

(* means equal contribution)

2024

7.  V. Adams*, S. Sarma*, C. K. Hall, A. Kennedy, "Development of MHC Class I peptides to target metabolic dysfunction-associated steatohepatitis CD8+ T cell activation", submitted, [bioRxiv].  

6.  S. Sarma*, T. R. Sudarshan, V. Nguyen, A.S. Robang, X. Xiao, J. V. Le, M. E. Helmicki, A. K. Paravastu, C. K. Hall, "Design of parallel 𝛽-sheet nanofibrils with Monte-Carlo search, coarse-grained simulations, and biophysical characterization”, under review, [bioRxiv]. 

2023

5. S. Sarma*, C. M. Catella*, E. S. Pedro, X. Xiao, D. Durmusoglu, S. Menegatti, N. Crook, S. T. Magness, C. K. Hall, "Design of 8-mer Peptide Inhibitors that Block Clostridioides difficile Toxin A in Intestinal Cells”, Commun. Biol. 2023, 10.1038/s42003-023-05242-x..

2022

4. X. Xiao*, A. S. Robang*,  S. Sarma*, J. V. Le, M. E. Helmicki, M. J. Lambert,  R. Guerrero-Ferreira, J. Arboleda-Echavarria, A. K. Paravastu, C. K. Hall. “Sequence Patterns and Signatures: Computational and Experimental Discovery of Amyloid-Forming Peptides”, PNAS Nexus 2022, 10.1093/pnasnexus/pgac263.

3. S. Sarma*, S. M. Herrera*, X. Xiao, G.A. Hudalla, C.K. Hall. “Computational Design and Experimental Validation of ACE2-derived Peptides as SARS-CoV-2 Receptor Binding Domain Inhibitors”, J. Phys. Chem. B. 2022, 10.1021/acs.jpcb.2c03918


2. X. Xiao*, R. Kilgore*, S. Sarma, S. Menegatti, C. K. Hall. “De novo Discovery of Peptide-based Affinity Ligands for the Fab Fragment of Human Immunoglobulin G”, Journal of Chromatography A. 2022, 10.1016/j.chroma.2022.462941. 

2021